Release of prostacyclin in vivo and its role in man. 1983

J M Ritter, and S E Barrow, and I A Blair, and C T Dollery

Concentrations of 6-oxo-prostaglandin F1 alpha (6-oxo-PGF1 alpha), the stable hydrolysis product of prostacyclin (PGI2) were determined in venous blood sampled from a forearm vein after dextrose (10% w/v) perfusion and after subsequent distension with physiological saline in seven healthy volunteers. 6-oxo-PGF1 alpha was measured by gas chromatography/negative ion chemical ionisation mass spectrometry. Local release of PGI2 was demonstrated in six volunteers: in three both stimuli were effective and in three only one stimulus was effective. In seven trained athletes studied before and after vigorous exercise baseline plasma concentrations of 6-oxo-PGF1 alpha were less than 1.3-3.2 pg/ml. The concentration increased after exercise in each subject (mean 10.9 pg/ml; range 5.5-18.2 pg/ml). Mild chemical and mechanical stimuli therefore can cause local production of PGI2 from human blood vessels in vivo.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
April 1983, Lancet (London, England),
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
June 1978, Nature,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
May 1979, British journal of pharmacology,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
June 1986, European journal of clinical investigation,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
June 1980, Prostaglandins,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
November 1985, Investigative radiology,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
September 1983, Nihon Jinzo Gakkai shi,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
December 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
December 1996, Prostaglandins, leukotrienes, and essential fatty acids,
J M Ritter, and S E Barrow, and I A Blair, and C T Dollery
January 1989, European journal of clinical pharmacology,
Copied contents to your clipboard!